null

Assistant Professor Wee Hwee Lin

BSc (Pharm) (Hons), National University of Singapore
PhD, National University of Singapore

Department of Pharmacy, National University of Singapore
18 Science Drive 4, Singapore 117543
Tel: +65 6516 5530
Fax: +65 6779 1554
Email: phawhl@nus.edu.sg

Research Focus

Pharmacoeconomics and Outcome Research, in particular, cost-effectiveness analysis of pharmaceuticals, pharmacogenetic tests and health services in the areas of Type 2 diabetes mellitus, colorectal cancer and breast cancer.

Awards (Post-PhD)

  • UK-Singapore Partners in Science Collaboration Award, 2012
  • International Society for Quality of Life Research New Investigator Award (Poster Category), 2011

Identifying a Cost-Effective Strategy for Mammography SCREENing in Singapore (ICE SCREEN Study)

Sponsor:   Ministry of Health Health Services Research Competitive Research Grant

Total project value:   $533,618.95

 

  • Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults”. Full text view only version available at http://em.rdcu.be/
  • A qualitative study on Singaporean women’s views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies. Available at http://rdcu.be/y0HO
  • Functional status mediates the association between peripheral neuropathy and health-related quality of life in individuals with diabetes. Available at http://rdcu.be/z26W

  • The associations of self-care, illness perceptions and psycological distress with metabolic control in Singapore adolescents with Type 1 Diabetes Mellitus. Available at http://www.tandfonline.com/doi/full/10.1080/21642850.2015.1115728
  • Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients. Available at http://hqlo.biomedcentral.com/articles/10.1186/s12955-016-0477-8
  • Could Values and Social Structures in Singapore Facilitate Attainment of Patient-Focused, Cultural, and Linguistic Competency Standards in a Patient-Centered Medical Home Pilot?
    Available at http://jpx.sagepub.com/content/2/2/37.full.pdf+html
  1. Mean Rank, Equipercentile and Regression Mapping of World Health Organization Quality of Life Brief (WHOQOL-BREF) to EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities. Accepted by Medical Decision Making in Nov 2017.
  2. Reliability and Validity of the English, Chinese and Malay language versions of the WHOQOL-BREF in Singapore. Accepted by Annals, Academy of Medicine Singapore in Nov 2017.
  3. Women Preferences, Willingness-to-Pay and Predicted Uptake for Single Nucleotide Polymorphisms Gene Testing to Guide Personalized Breast Cancer Screening Strategies: A Discrete Choice Experiment.
  4. EQ-5D health status as predictor of health services utilization.
  5. Cost-effectiveness of various patient selection protocols (who to test, when to test and what to test) in preemptive pharmacogenotyping.

Current:

  • Miss Wong Xinyi, commenced Aug 2015
    Thesis title: Patient preferences for cancer screening and treatments

Graduated: 

  • Ms. Wang Wei, Vivian, conferred Jan 2017
    Thesis title: Economic and Health-Related Quality of Life Outcomes among Community-Dwelling Dementia Patients in Singapore
  • Miss Soon Swee Sung, conferred Aug 2017
    Thesis title: The Cost-effectiveness of Aspirin in Colorectal Cancer Prevention

Co-supervisor: Dr John Chia, National Cancer Center Singapore

  • Mr Mcvin Cheen Hua Heng (Part-time), conferred Aug 2017
    Thesis title: Evaluating the Outcomes and Cost-effectiveness of Ambulatory Care Pharmacy Services in Singapore
  • Mr Casper Keegan Lin Rongrui (Part-time), conferred Aug 2017
    Thesis title: Oncology patients’ beliefs in supportive care and their adherence
  • Dr Gan Hua Pey, conferred 2014
    Thesis title: Developing workplace-based smoking cessation programme in Sinagpore.
Co-supervisor: Professor Li Shu Chuen, Visiting Professor, Department of Pharmacy, NUS
  • Dr Ow Yen Ling Mandy, conferred 2012
    Thesis title: Assessing Health-Related Quality of Life and the Economic Cost of Systemic Lupus Erythematosus in Singapore.
    Co-supervisors: A/P Julian Thumboo, Senior Consultant and Head, Department of Rheumatology & Immunology, Singapore General Hospital; Professor Li Shu Chuen, Visiting Professor, Department of Pharmacy, NUS
  • Dr Zhao Yingjiao, conferred 2010
    Thesis title: Pharmacoeconomics and Health Outcomes Research Amongst Asian Parkinson’s Disease Patients in Singapore.
    Co-supervisors: Professor Li Shu Chuen, Visiting Professor, Department of Pharmacy, NUS; Dr Luo Nan, Assistant Professor, Department of Epidemiology & Public Health, NUS.
  • Dr Tipaporn Pongmesa, conferred 2010
    Thesis title: Management of Diabetes Mellitus in Asia: A comparison between Thailand and Singapore.
    Co-supervisor: Professor Li Shu Chuen, Visiting Professor, Department of Pharmacy, NUS.
  • Novartis Asia Pacific Pharmaceuticals Pte Ltd
  • AbbVie Ptd Ltd
  • Pfizer Pte Ltd
  • National Healthcare Group, Singapore
  • Singapore Health Services

2017-11-18-16-03-20

Honoured to share the stage with Christophe Le Tourneau, senior medical oncologist at the Institut Curie and Professor of Medicine at the Versailles-Saint-Quentin-en-Yvelines University and Jan Bogaerts, Scientific Director of EORTC. Interesting discussion on how to design clinical trials for precision medicine.